You are here Home Guidance and resources Articles Search our media releases, news, safety updates, reports and notices. Listen Print Share RSS feed Loading... Use the filters below to narrow your search. Filter results Open all Close all You can narrow down the results using the filters. Audience Health professionals (1) (-) Health professionals (1) Consumers (2) Consumers (2) Sponsors (1) Sponsors (1) Product type Medicine (1) Medicine (1) Topic Non-prescription medicines (1) (-) Non-prescription medicines (1) Medicine safety (54) Medicine safety (54) Safety (16) Safety (16) Prescription medicines (13) Prescription medicines (13) Alert/Advisory (7) Alert/Advisory (7) COVID-19 vaccines (4) COVID-19 vaccines (4) Labelling and packaging (1) Labelling and packaging (1) Over the counter (OTC) medicines (1) Over the counter (OTC) medicines (1) Therapeutic goods regulation (1) Therapeutic goods regulation (1) Show more Type of content Safety updates (1) (-) Safety updates (1) Media releases (6) Media releases (6) News (2) News (2) Notices (1) Notices (1) Published date 2024 (1) 2024 (1) Order A-Z Z-A Sort by Relevance Latest Title Sort by Relevance Latest Title (A-Z) Title (Z-A) Filters applied:Health professionalsNon-prescription medicinesSafety updatesClear all Search1 result(s) found, displaying 1 to 1 Promethazine hydrochloride (Phenergan) not to be used in children under 6 19 November 2024 Safety updates Health professionals and consumers are advised that the oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be used in children under 6 years of age.
Promethazine hydrochloride (Phenergan) not to be used in children under 6 19 November 2024 Safety updates Health professionals and consumers are advised that the oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be used in children under 6 years of age.